Accord Logo

Intended for UK patients and members of the public

SmPC - Pravastatin Sodium 20mg Tablets: Change history

  • Description of update: To update section 4.8 of the SmPC and section 4 of the PIL to implement the wording agreed by PRAC following the outcome of the PSUR procedure PSUSA/00002500/202303. Additional typographical amends have been made in the PIL.

    SmPC Sections updated: 4.8 and 10.

    • Changes: (Updated: 08 Apr 2024)

      Description of update: To update section 4.8 of the SmPC and section 4 of the PIL to implement the wording agreed by PRAC following the outcome of the PSUR procedure PSUSA/00002500/202303. Additional typographical amends have been made in the PIL.

      SmPC Sections updated: 4.8 and 10.

    • Changes: (Updated: 16 Nov 2023)

      Description of update: Update of the sections 4.4, 4.5, 4.8 and 5.3 of SmPC and section 2,3 and 4 of PIL in line with the information of Reference product (SELECTIN 10mg/20 mg/40mg compresse; EU procedure number: FR/H/0252/001-003; MAH: Bristol-Myers Squibb S.r.l., Italy) for Pravastatin Sodium 10mg/20mg/40mg Tablets. Additionally, updated of the sections 4.4, 4.5 of SmPC and section 2 of PIL with editorial changes, section 2 of PIL with QRD template related changes.

      SmPC Sections updated: 4.4, 4.5, 4.8, 5.3 and 10.

    • Changes: (Updated: 19 Jun 2023)

      No changes to file- Website administration only

    • Changes: (Updated: 19 Jun 2023)

      Description of update: Type IAin: C.I.z - to update SmPC section 4.4, 4.8 and PIL section 2 and 4 to include adverse reactions with a frequency not known: myasthenia gravis and ocular myasthenia as per PRAC recommendations on signals adopted at the 9-12 January 2023.

      SmPC sections updated: 4.4, 4.8, 10.

    • Changes: (Updated: 21 Sep 2022)

      Initial upload

    View product information as a: